此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Effects of Supplementation on Performance in Football Players (FOOTBALL-TCP)

2026年5月21日 更新者:Krzysztof Mizera

Effects of Combined Taurine, Caffeine, and Phosphatidylserine Supplementation on Physical and Cognitive Performance in Professional Male Football Players

This study investigated the effects of short-term supplementation with taurine, caffeine, and phosphatidylserine on physical and cognitive performance in professional male football players. Eighty-one players were randomly assigned to one of three groups: placebo, taurine plus caffeine, or taurine plus caffeine combined with phosphatidylserine. Supplementation was administered for 10 days, with a final dose taken 60 minutes before a standardized 105-minute football training session.

Primary and secondary outcomes included sprint performance, reaction time, GPS-derived locomotor variables, and technical and tactical performance indicators. The aim of the study was to evaluate whether combined multi-ingredient supplementation could improve performance and attenuate fatigue-related declines under match-like conditions.

研究概览

详细说明

This randomized, placebo-controlled, single-blind study evaluated the effects of combined supplementation with taurine, caffeine, and phosphatidylserine on physical and cognitive performance in professional male football players.

Eighty-one participants aged 19-32 years were randomly assigned to one of three groups: placebo (lactose), taurine plus caffeine (1500 mg taurine + 200 mg caffeine), or taurine plus caffeine plus phosphatidylserine (1500 mg taurine + 150 mg caffeine + 300 mg phosphatidylserine daily for 10 days). All participants completed a 10-day supplementation period, followed by a standardized 105-minute football training session.

Outcome measures included sprint performance (30 m sprint time), reaction time (visual and auditory), GPS-derived variables (total distance, sprint activity, speed, accelerations, and decelerations), and technical and tactical performance indicators assessed by coaching staff and video analysis.

The study was conducted under controlled environmental conditions and in accordance with standardized training procedures. Data were analyzed using analysis of variance (ANOVA) with post hoc testing. The aim was to determine whether multi-ingredient supplementation could enhance performance and reduce fatigue-related declines in a football-specific setting.

研究类型

介入性

注册 (实际的)

81

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Łódżkie
      • Lodz、Łódżkie、波兰、94-020
        • ŁKS Łódź

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人

接受健康志愿者

是的

描述

Inclusion Criteria:

  • Male professional football (soccer) players
  • Age 19-32 years
  • Currently participating in regular team training (4-5 sessions per week)
  • Medically cleared for participation in high-intensity physical activity
  • Provided written informed consent

Exclusion Criteria:

  • Current injury or musculoskeletal condition affecting performance
  • Chronic disease or medical condition
  • Use of medications that may affect physical or cognitive performance
  • Regular use of dietary supplements or caffeine prior to the study period
  • Smoking or alcohol consumption
  • Failure to comply with study procedures

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:基础科学
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
安慰剂比较:Placebo
Participants received a placebo (lactose) daily for 10 days.
Placebo (lactose) administered daily for 10 days
实验性的:Taurine + Caffeine
Participants received taurine (1500 mg) and caffeine (200 mg) daily for 10 days.
Taurine 1500 mg and caffeine 200 mg administered daily for 10 days
实验性的:Taurine + Caffeine + PS
Participants received taurine (1500 mg), caffeine (150 mg), and phosphatidylserine (300 mg) daily for 10 days.
Taurine 1500 mg, caffeine 150 mg, and phosphatidylserine 300 mg administered daily for 10 days

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
30 m sprint time (seconds)
大体时间:Day 10 (final training session following supplementation)
Time to complete a 30 meter sprint under standardized conditions, expressed in seconds; calculated as the mean of valid trials.
Day 10 (final training session following supplementation)

次要结果测量

结果测量
措施说明
大体时间
Reaction time (visual and auditory)
大体时间:Day 10 (post-supplementation)
Visual and auditory reaction time measured using standardized computerized reaction time tests (e.g., validated software-based assessment tools), expressed as mean response time in seconds across valid trials.
Day 10 (post-supplementation)
Total distance (meters)
大体时间:Day 10 (during standardized training session)
Total distance covered during the standardized training session, measured using GPS tracking devices (e.g., 10 Hz GPS units), expressed in meters.
Day 10 (during standardized training session)
Running speed (m/s)
大体时间:Day 10 (during standardized training session)
Mean running speed during the standardized training session, measured using GPS tracking devices (e.g., 10 Hz GPS units), expressed in meters per second.
Day 10 (during standardized training session)
Sprint count (number)
大体时间:Day 10 (during standardized training session)
Total number of sprint efforts recorded during the standardized training session using GPS tracking devices.
Day 10 (during standardized training session)
High-speed running distance (meters)
大体时间:Day 10 (during standardized training session)
Distance covered at high-speed running thresholds during the standardized training session, measured using GPS tracking and expressed in meters.
Day 10 (during standardized training session)

其他结果措施

结果测量
措施说明
大体时间
Sprint time decline (%)
大体时间:Day 10 (during final training session; comparison between first and second halves)
Percentage decline in 30 m sprint time between the first and second halves of the standardized training session, measured using electronic timing gates and expressed as percentage change.
Day 10 (during final training session; comparison between first and second halves)
Running speed decline (%)
大体时间:Day 10 (during final training session; comparison between first and second halves)
Percentage decline in running speed between the first and second halves of the standardized training session, measured using GPS tracking devices and expressed as percentage change.
Day 10 (during final training session; comparison between first and second halves)
Passing accuracy (%)
大体时间:Day 10 (during standardized training session)
Percentage of successful passes during the standardized training session, assessed using video-based performance analysis and expressed as a percentage.
Day 10 (during standardized training session)
Dribbling success (%)
大体时间:Day 10 (during standardized training session)
Percentage of successful dribbling attempts during the standardized training session, assessed using video-based performance analysis and expressed as a percentage.
Day 10 (during standardized training session)
Ball recoveries (number)
大体时间:Day 10 (during standardized training session)
Total number of ball recoveries performed during the standardized training session, assessed using video-based performance analysis and expressed as a count.
Day 10 (during standardized training session)
Tactical performance score (units)
大体时间:Day 10 (during standardized training session)
Coach-rated tactical performance during the standardized training session, including positioning, decision-making, and support play, assessed using a standardized rating scale and expressed in standardized score units.
Day 10 (during standardized training session)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Krzysztof Maciej MIZERA, PhD、1. Vizja University in Warsaw, Faculty of Medical Sciences and Health Sciences, 01-143 Warsaw, Poland

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年3月25日

初级完成 (实际的)

2025年4月5日

研究完成 (实际的)

2025年4月5日

研究注册日期

首次提交

2026年4月28日

首先提交符合 QC 标准的

2026年5月5日

首次发布 (实际的)

2026年5月12日

研究记录更新

最后更新发布 (实际的)

2026年5月26日

上次提交的符合 QC 标准的更新

2026年5月21日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

Individual participant data will not be publicly available due to confidentiality restrictions related to professional athletes. Data may be available from the corresponding author upon reasonable request.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅